NASDAQ
No price data available for this timeframe.
AnaptysBio, Inc. (ANAB) has a current ratio of 9.07x as of Monday, May 25, 2026. This represents a 49.58% decrease compared to its 12-month average of 17.99x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.